| Insideraktier | 2.439.885 shares |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Netto antal insidere, der køber (rang)
N/A
Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).
Procent af float købt af insidere (rangering)
N/A
Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.
Insiderhandelsdiagram
ARMO BioSciences, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ARMO / ARMO BioSciences, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Maks |
Pris kl Maks |
Maks Fortjeneste ($) |
Maks. afkast (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ARMO / ARMO BioSciences, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-06-22 | 2018-06-22 | 4 | Xu Stella | ARMO | Stock Option (right to buy) | D | 39,97 | 10,0300 | -18.000 | -181 | 0 | |||
| 2018-06-22 | 2018-06-22 | 4 | Xu Stella By Quan Venture Fund I, L.P. | ARMO | Common Stock | I | 50,0000 | -404.900 | -20.245 | 0 | ||||
| 2018-06-22 | 2018-06-22 | 4 | SEIDENBERG BETH C | ARMO | Stock Option (right to buy) | D | 39,97 | 10,0300 | -18.000 | -181 | 0 | |||
| 2018-06-22 | 2018-06-22 | 4 | SEIDENBERG BETH C By KPCB Holdings, Inc., as nominee | ARMO | Common Stock | I | 50,0000 | -4.266.683 | -213.334 | 0 | ||||
| 2018-06-22 | 2018-06-22 | 4 | Cui Xiangmin | ARMO | Stock Option (right to buy) | D | 39,97 | 10,0300 | -18.000 | -181 | 0 | |||
| 2018-06-22 | 2018-06-22 | 4 | Cui Xiangmin By Decheng Capital China Life Sciences USD Fund II, L.P. | ARMO | Common Stock | I | 50,0000 | -1.214.700 | -60.735 | 0 | ||||
| 2018-06-22 | 2018-06-22 | 4 | CROSS HERB | ARMO | Stock Option (right to buy) | D | 6,97 | 43,0302 | -240.658 | -10.356 | 0 | |||
| 2018-06-22 | 2018-06-22 | 4 | Kleiner Perkins Caufield & Byers XIV, LLC By KPCB Holdings, Inc., as nominee | ARMO | Common Stock | I | 50,0000 | -4.266.683 | -213.334 | 0 | ||||
| 2018-06-22 | 2018-06-22 | 4 | Rizvi Naiyer | ARMO | Stock Option (right to buy) | D | 6,73 | 43,2657 | -19.146 | -828 | 0 | |||
| 2018-06-22 | 2018-06-22 | 4 | Rizvi Naiyer | ARMO | Stock Option (right to buy) | D | 39,97 | 10,0300 | -18.000 | -181 | 0 | |||
| 2018-06-22 | 2018-06-22 | 4 | Legault Pierre | ARMO | Stock Option (right to buy) | D | 6,73 | 43,2657 | -55.765 | -2.413 | 0 | |||
| 2018-06-22 | 2018-06-22 | 4 | Legault Pierre | ARMO | Stock Option (right to buy) | D | 39,97 | 10,0300 | -18.000 | -181 | 0 | |||
| 2018-06-22 | 2018-06-22 | 4 | ORBIMED ADVISORS LLC By OrbiMed Private Investments V, LP | ARMO | Common Stock | I | 50,0000 | -409.547 | -20.477 | 409.547 | ||||
| 2018-06-22 | 2018-06-22 | 4 | ORBIMED ADVISORS LLC By OrbiMed Private Investments IV, LP | ARMO | Common Stock | I | 50,0000 | -3.709.356 | -185.468 | 3.709.356 | ||||
| 2018-06-22 | 2018-06-22 | 4 | VAN VLASSELAER PETER | ARMO | Stock Option (right to buy) | D | 6,97 | 43,0302 | -216.168 | -9.302 | 0 | |||
| 2018-06-22 | 2018-06-22 | 4 | VAN VLASSELAER PETER | ARMO | Stock Option (right to buy) | D | 3,30 | 46,7035 | -398.206 | -18.598 | 0 | |||
| 2018-06-22 | 2018-06-22 | 4 | VAN VLASSELAER PETER | ARMO | Stock Option (right to buy) | D | 1,32 | 48,6814 | -220.513 | -10.735 | 0 | |||
| 2018-06-22 | 2018-06-22 | 4 | VAN VLASSELAER PETER | ARMO | Stock Option (right to buy) | D | 1,32 | 48,6814 | -190.641 | -9.281 | 0 | |||
| 2018-06-22 | 2018-06-22 | 4 | VAN VLASSELAER PETER | ARMO | Common Stock | D | 50,0000 | -809.865 | -40.493 | 0 | ||||
| 2018-06-22 | 2018-06-22 | 4 | Leveque Joseph | ARMO | Stock Option (right to buy) | D | 6,97 | 43,0302 | -288.789 | -12.427 | 0 | |||
| 2018-06-22 | 2018-06-22 | 4 | GORDON CARL L | ARMO | Stock Option (right to buy) | D | 39,97 | 10,0300 | -18.000 | -181 | 0 | |||
| 2018-06-22 | 2018-06-22 | 4 | GORDON CARL L By OrbiMed Private Investments V, LP | ARMO | Common Stock | I | 50,0000 | -409.547 | -20.477 | 0 | ||||
| 2018-06-22 | 2018-06-22 | 4 | GORDON CARL L By OrbiMed Private Investments IV, LP | ARMO | Common Stock | I | 50,0000 | -3.709.356 | -185.468 | 0 | ||||
| 2018-03-28 | 2018-03-26 | 4 | Cui Xiangmin | ARMO | Stock Option (right to buy) | D | 39,97 | 18.000 | 18.000 | |||||
| 2018-03-28 | 2018-03-26 | 4 | SEIDENBERG BETH C | ARMO | Stock Option (right to buy) | D | 39,97 | 18.000 | 18.000 | |||||
| 2018-03-28 | 2018-03-26 | 4 | Rizvi Naiyer | ARMO | Stock Option (right to buy) | D | 39,97 | 18.000 | 18.000 | |||||
| 2018-03-28 | 2018-03-26 | 4 | Legault Pierre | ARMO | Stock Option (right to buy) | D | 39,97 | 18.000 | 18.000 | |||||
| 2018-03-28 | 2018-03-26 | 4 | GORDON CARL L | ARMO | Stock Option (right to buy) | D | 39,97 | 18.000 | 18.000 | |||||
| 2018-03-28 | 2018-03-26 | 4 | Xu Stella | ARMO | Stock Option (right to buy) | D | 39,97 | 18.000 | 18.000 | |||||
| 2018-02-01 | 2018-01-30 | 4 | SC China Venture VI Management, L.P. By SCC Venture VI Holdco, Ltd. | ARMO | Series C-1 Preferred Stock | I | -809.800 | 0 | ||||||
| 2018-02-01 | 2018-01-30 | 4 | SC China Venture VI Management, L.P. By SCC Venture VI Holdco, Ltd. | ARMO | Common Stock | I | 809.800 | 809.800 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | DAG Ventures Management V, LLC By DAG Ventures V, L.P. | ARMO | Series C-1 Preferred Stock | I | -446 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | DAG Ventures Management V, LLC By DAG Ventures V-QP, L.P. | ARMO | Series C-1 Preferred Stock | I | -183.351 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | DAG Ventures Management V, LLC By DAG Ventures V, L.P. | ARMO | Series C Preferred Stock | I | -551 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | DAG Ventures Management V, LLC By DAG Ventures V-QP, L.P. | ARMO | Series C Preferred Stock | I | -226.543 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | DAG Ventures Management V, LLC By DAG Ventures V, L.P. | ARMO | Series B-1 Preferred Stock | I | -489 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | DAG Ventures Management V, LLC By DAG Ventures V-QP, L.P. | ARMO | Series B-1 Preferred Stock | I | -200.786 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | DAG Ventures Management V, LLC By DAG Ventures V, L.P. | ARMO | Series B Preferred Stock | I | -1.772 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | DAG Ventures Management V, LLC By DAG Ventures V-QP, L.P. | ARMO | Series B Preferred Stock | I | -728.080 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | DAG Ventures Management V, LLC By DAG Ventures V, L.P. | ARMO | Series A Preferred Stock | I | -2.580 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | DAG Ventures Management V, LLC By DAG Ventures V-QP, L.P. | ARMO | Series A Preferred Stock | I | -1.059.148 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | DAG Ventures Management V, LLC By DAG Ventures V, L.P. | ARMO | Common Stock | I | 446 | 5.838 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | DAG Ventures Management V, LLC By DAG Ventures V-QP, L.P. | ARMO | Common Stock | I | 183.351 | 2.397.908 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | DAG Ventures Management V, LLC By DAG Ventures V, L.P. | ARMO | Common Stock | I | 551 | 5.392 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | DAG Ventures Management V, LLC By DAG Ventures V-QP, L.P. | ARMO | Common Stock | I | 226.543 | 2.214.557 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | DAG Ventures Management V, LLC By DAG Ventures V, L.P. | ARMO | Common Stock | I | 489 | 4.841 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | DAG Ventures Management V, LLC By DAG Ventures V-QP, L.P. | ARMO | Common Stock | I | 200.786 | 1.988.014 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | DAG Ventures Management V, LLC By DAG Ventures V, L.P. | ARMO | Common Stock | I | 1.772 | 4.352 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | DAG Ventures Management V, LLC By DAG Ventures V-QP, L.P. | ARMO | Common Stock | I | 728.080 | 1.787.228 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | DAG Ventures Management V, LLC By DAG Ventures V, L.P. | ARMO | Common Stock | I | 2.580 | 2.580 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | DAG Ventures Management V, LLC By DAG Ventures V-QP, L.P. | ARMO | Common Stock | I | 1.059.148 | 1.059.148 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | GV 2016 GP, L.L.C. By GV 2016, L.P. | ARMO | Series C-1 Convertible Preferred Stock | I | -607.350 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | GV 2016 GP, L.L.C. By GV 2016, L.P. | ARMO | Common Stock | I | 607.350 | 607.350 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | Kleiner Perkins Caufield & Byers XIV, LLC By KPCB Holdings, Inc., as nominee | ARMO | Series C-1 Convertible Preferred Stock | I | -326.242 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | Kleiner Perkins Caufield & Byers XIV, LLC By KPCB Holdings, Inc., as nominee | ARMO | Series C Convertible Preferred Stock | I | -403.097 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | Kleiner Perkins Caufield & Byers XIV, LLC By KPCB Holdings, Inc., as nominee | ARMO | Series B-1 Convertible Preferred Stock | I | -355.429 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | Kleiner Perkins Caufield & Byers XIV, LLC By KPCB Holdings, Inc., as nominee | ARMO | Series B Convertible Preferred Stock | I | -1.296.248 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | Kleiner Perkins Caufield & Byers XIV, LLC By KPCB Holdings, Inc., as nominee | ARMO | Series A Convertible Preferred Stock | I | -1.212.494 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | Kleiner Perkins Caufield & Byers XIV, LLC By KPCB Holdings, Inc., as nominee | ARMO | Series A-1 Convertible Preferred Stock | I | -673.173 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | Kleiner Perkins Caufield & Byers XIV, LLC By KPCB Holdings, Inc., as nominee | ARMO | Common Stock | I | 4.266.683 | 4.266.683 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | Cui Xiangmin By Decheng Capital China Life Sciences USD Fund II, L.P. | ARMO | Series C-1 Convertible Preferred Stock | I | -1.214.700 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | Cui Xiangmin By Decheng Capital China Life Sciences USD Fund II, L.P. | ARMO | Common Stock | I | 1.214.700 | 1.214.700 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | GV 2014 GP, L.L.C. By GV 2014, L.P. | ARMO | Series C Convertible Preferred Stock | I | -607.350 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | GV 2014 GP, L.L.C. By GV 2014, L.P. | ARMO | Common Stock | I | 607.350 | 607.350 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | Xu Stella By Quan Venture Fund I, L.P. | ARMO | Series C-1 Convertible Preferred Stock | I | -404.900 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | Xu Stella By Quan Venture Fund I, L.P. | ARMO | Common Stock | I | 404.900 | 404.900 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | SEIDENBERG BETH C By KPCB Holdings, Inc., as nominee | ARMO | Series C-1 Convertible Preferred Stock | I | -326.242 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | SEIDENBERG BETH C By KPCB Holdings, Inc., as nominee | ARMO | Series C Convertible Preferred Stock | I | -403.097 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | SEIDENBERG BETH C By KPCB Holdings, Inc., as nominee | ARMO | Series B-1 Convertible Preferred Stock | I | -355.429 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | SEIDENBERG BETH C By KPCB Holdings, Inc., as nominee | ARMO | Series B Convertible Preferred Stock | I | -1.296.248 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | SEIDENBERG BETH C By KPCB Holdings, Inc., as nominee | ARMO | Series A Convertible Preferred Stock | I | -1.212.494 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | SEIDENBERG BETH C By KPCB Holdings, Inc., as nominee | ARMO | Series A-1 Convertible Preferred Stock | I | -673.173 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | SEIDENBERG BETH C By KPCB Holdings, Inc., as nominee | ARMO | Common Stock | I | 4.266.683 | 4.266.683 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | GORDON CARL L By OrbiMed Private Investments V, LP | ARMO | Series C-1 Convertible Preferred Stock | I | -31.315 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | GORDON CARL L By OrbiMed Private Investments V, LP | ARMO | Series C Convertible Preferred Stock | I | -45.961 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | GORDON CARL L By OrbiMed Private Investments V, LP | ARMO | Series B-1 Convertible Preferred Stock | I | -332.271 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | GORDON CARL L By OrbiMed Private Investments IV, LP | ARMO | Series C-1 Convertible Preferred Stock | I | -283.627 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | GORDON CARL L By OrbiMed Private Investments IV, LP | ARMO | Series C Convertible Preferred Stock | I | -415.869 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | GORDON CARL L By OrbiMed Private Investments IV, LP | ARMO | Series B Convertible Preferred Stock | I | -1.226.156 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | GORDON CARL L By OrbiMed Private Investments IV, LP | ARMO | Series A Convertible Preferred Stock | I | -1.783.704 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | GORDON CARL L By OrbiMed Private Investments V, LP | ARMO | Common Stock | I | 409.547 | 409.547 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | GORDON CARL L By OrbiMed Private Investments IV, LP | ARMO | Common Stock | I | 3.709.356 | 3.709.356 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | ORBIMED ADVISORS LLC By OrbiMed Private Investments V, LP | ARMO | Series C-1 Convertible Preferred Stock | I | -31.315 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | ORBIMED ADVISORS LLC By OrbiMed Private Investments V, LP | ARMO | Series C Convertible Preferred Stock | I | -45.961 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | ORBIMED ADVISORS LLC By OrbiMed Private Investments V, LP | ARMO | Series B-1 Convertible Preferred Stock | I | -332.271 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | ORBIMED ADVISORS LLC By OrbiMed Private Investments IV, LP | ARMO | Series C-1 Convertible Preferred Stock | I | -283.627 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | ORBIMED ADVISORS LLC By OrbiMed Private Investments IV, LP | ARMO | Series C Convertible Preferred Stock | I | -415.869 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | ORBIMED ADVISORS LLC By OrbiMed Private Investments IV, LP | ARMO | Series B Convertible Preferred Stock | I | -1.226.156 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | ORBIMED ADVISORS LLC By OrbiMed Private Investments IV, LP | ARMO | Series A Convertible Preferred Stock | I | -1.783.704 | 0 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | ORBIMED ADVISORS LLC By OrbiMed Private Investments V, LP | ARMO | Common Stock | I | 409.547 | 409.547 | ||||||
| 2018-01-30 | 2018-01-30 | 4 | ORBIMED ADVISORS LLC By OrbiMed Private Investments IV, LP | ARMO | Common Stock | I | 3.709.356 | 3.709.356 | ||||||
| 2018-01-25 | 3 | VAN VLASSELAER PETER | ARMO | Common Stock | D | 1.619.730 | ||||||||
| 2018-01-25 | 3 | VAN VLASSELAER PETER | ARMO | Common Stock | D | 1.619.730 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
